LQDA
Liquidia Corp
NASDAQ · Healthcare · Biotechnology · US
$44.99
−1.60%Forward multiples
Based on analyst estimates
- P/E forward
- 42.92x
- P/E 2026E
- 21.34x
- P/E 2027E
- 20.41x
- P/E 2028E
- 13.50x
- P/S forward
- 5.18x
Trailing multiples
Trailing twelve months
- P/E TTM
- 28.67x
- PEG TTM
- —
- Price / book
- 20.64x
- Price / sales
- 8.93x
- Price / cash flow
- 50.95x
Enterprise value
- Enterprise value
- $3.9B
- EV / sales
- 8.59x
- EV / EBITDA
- 21.77x
- EV / EBIT
- 22.97x
- Market cap
- $4.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026